CLB Quote, Financials, Valuation and Earnings

Dawson Geophysical Co. has a net margin of 10.8% compared to Core Laboratories Inc.'s net margin of -5.07%. Core Laboratories Inc.'s return on equity of 12.42% beat Dawson Geophysical Co.'s return on equity of -19.39%.

Core Laboratories Inc. has a consensus price target of $14.00, signalling downside risk potential of -26.2%. On the other hand Dawson Geophysical Co. has an analysts' consensus of -- which suggests that it could grow by 127.27%. Given that Dawson Geophysical Co. has higher upside potential than Core Laboratories Inc., analysts believe Dawson Geophysical Co. is more attractive than Core Laboratories Inc..

Core Laboratories Inc. has a beta of 1.035, which suggesting that the stock is 3.479% more volatile than S&P 500. In comparison Dawson Geophysical Co. has a beta of -0.087, suggesting its less volatile than the S&P 500 by 108.689%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.21%. Dawson Geophysical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.32 per share. Core Laboratories Inc. pays 5.98% of its earnings as a dividend. Dawson Geophysical Co. pays out 239.38% of its earnings as a dividend. Core Laboratories Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Dawson Geophysical Co.'s is not.

Core Laboratories Inc. quarterly revenues are $134.5M, which are larger than Dawson Geophysical Co. quarterly revenues of $22.7M. Core Laboratories Inc.'s net income of $14.5M is higher than Dawson Geophysical Co.'s net income of -$1.2M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.95x while Dawson Geophysical Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.73x versus 0.85x for Dawson Geophysical Co.. Usually stocks with elevated PS ratios are considered overvalued.

TechnipFMC plc has a net margin of 10.8% compared to Core Laboratories Inc.'s net margin of 11.77%. Core Laboratories Inc.'s return on equity of 12.42% beat TechnipFMC plc's return on equity of 29.34%.

Core Laboratories Inc. has a consensus price target of $14.00, signalling downside risk potential of -26.2%. On the other hand TechnipFMC plc has an analysts' consensus of $48.48 which suggests that it could fall by -3.19%. Given that Core Laboratories Inc. has more downside risk than TechnipFMC plc, analysts believe TechnipFMC plc is more attractive than Core Laboratories Inc..

Core Laboratories Inc. has a beta of 1.035, which suggesting that the stock is 3.479% more volatile than S&P 500. In comparison TechnipFMC plc has a beta of 0.663, suggesting its less volatile than the S&P 500 by 33.658%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.21%. TechnipFMC plc offers a yield of 0.4% to investors and pays a quarterly dividend of $0.05 per share. Core Laboratories Inc. pays 5.98% of its earnings as a dividend. TechnipFMC plc pays out 10.45% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories Inc. quarterly revenues are $134.5M, which are smaller than TechnipFMC plc quarterly revenues of $2.6B. Core Laboratories Inc.'s net income of $14.5M is lower than TechnipFMC plc's net income of $310.9M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.95x while TechnipFMC plc's PE ratio is 22.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.73x versus 2.17x for TechnipFMC plc. Usually stocks with elevated PS ratios are considered overvalued.

Halliburton Co. has a net margin of 10.8% compared to Core Laboratories Inc.'s net margin of 0.36%. Core Laboratories Inc.'s return on equity of 12.42% beat Halliburton Co.'s return on equity of 12.64%.

Core Laboratories Inc. has a consensus price target of $14.00, signalling downside risk potential of -26.2%. On the other hand Halliburton Co. has an analysts' consensus of $31.72 which suggests that it could fall by -2.79%. Given that Core Laboratories Inc. has more downside risk than Halliburton Co., analysts believe Halliburton Co. is more attractive than Core Laboratories Inc..

Core Laboratories Inc. has a beta of 1.035, which suggesting that the stock is 3.479% more volatile than S&P 500. In comparison Halliburton Co. has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.851%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.21%. Halliburton Co. offers a yield of 2.08% to investors and pays a quarterly dividend of $0.17 per share. Core Laboratories Inc. pays 5.98% of its earnings as a dividend. Halliburton Co. pays out 24.01% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories Inc. quarterly revenues are $134.5M, which are smaller than Halliburton Co. quarterly revenues of $5.6B. Core Laboratories Inc.'s net income of $14.5M is lower than Halliburton Co.'s net income of $20M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.95x while Halliburton Co.'s PE ratio is 21.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.73x versus 1.27x for Halliburton Co.. Usually stocks with elevated PS ratios are considered overvalued.

SLB Ltd. has a net margin of 10.8% compared to Core Laboratories Inc.'s net margin of 8.68%. Core Laboratories Inc.'s return on equity of 12.42% beat SLB Ltd.'s return on equity of 16.49%.

Core Laboratories Inc. has a consensus price target of $14.00, signalling downside risk potential of -26.2%. On the other hand SLB Ltd. has an analysts' consensus of $47.30 which suggests that it could grow by 4.64%. Given that SLB Ltd. has higher upside potential than Core Laboratories Inc., analysts believe SLB Ltd. is more attractive than Core Laboratories Inc..

Core Laboratories Inc. has a beta of 1.035, which suggesting that the stock is 3.479% more volatile than S&P 500. In comparison SLB Ltd. has a beta of 0.718, suggesting its less volatile than the S&P 500 by 28.18%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.21%. SLB Ltd. offers a yield of 2.52% to investors and pays a quarterly dividend of $0.29 per share. Core Laboratories Inc. pays 5.98% of its earnings as a dividend. SLB Ltd. pays out 35.41% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories Inc. quarterly revenues are $134.5M, which are smaller than SLB Ltd. quarterly revenues of $8.9B. Core Laboratories Inc.'s net income of $14.5M is lower than SLB Ltd.'s net income of $774M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.95x while SLB Ltd.'s PE ratio is 17.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.73x versus 1.81x for SLB Ltd.. Usually stocks with elevated PS ratios are considered overvalued.